Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014 (2014), Article ID 834389, 6 pages
http://dx.doi.org/10.1155/2014/834389
Research Article

Serum Level of Antibody against Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA Adducts in People Dermally Exposed to PAHs

1Institute of Pathological Physiology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, 50038 Hradec Kralove, Czech Republic
2Institute of Clinical Immunology and Allergology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, 50038 Hradec Kralove, Czech Republic
3Institute of Clinical Biochemistry and Diagnosis, Charles University in Prague, Faculty of Medicine in Hradec Kralove, 50038 Hradec Kralove, Czech Republic
4Clinic of Dermal and Venereal Diseases, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech Republic
5Institute of Hygiene and Preventive Medicine, Charles University in Prague, Faculty of Medicine in Hradec Kralove, 50038 Hradec Kralove, Czech Republic

Received 10 February 2014; Accepted 26 March 2014; Published 13 April 2014

Academic Editor: Bin Zhang

Copyright © 2014 Lenka Borska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Pauk, S. Klimesova, J. Kara et al., “The relevance of monitoring of antibodies against the polycyclic aromatic hydrocarbon (PAH) and PAH-DNA adducts in serum in relation to lung cancer and chronic obstructive pulmonary disease (COPD),” Neoplasma, vol. 60, pp. 182–187, 2013. View at Google Scholar
  2. Z. Fiala, L. Borska, A. Pastorkova et al., “Genotoxic effect of Goeckerman regimen of psoriasis,” Archives of Dermatological Research, vol. 298, no. 5, pp. 243–251, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. H. J. Roelofzen, P. G. M. van der Valk, R. Godschalk et al., “DNA adducts in skin biopsies and 1-hydroxypyrene in urine of psoriasis patients and healthy volunteers following treatment with coal tar,” Toxicology Letters, vol. 213, pp. 39–44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. H. U. Käfferlein, B. Marczynski, T. Mensing, and T. Brüning, “Albumin and hemoglobin adducts of benzo[a]pyrene in humans-analytical methods, exposure assessment, and recommendations for future directions,” Critical Reviews in Toxicology, vol. 40, no. 2, pp. 126–150, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Petruzzelli, A. Celi, N. Pulerà et al., “Serum antibodies to benzo(a)pyrene diol epoxide-DNA adducts in the general population: effects of air pollution, tobacco smoking, and family history of lung diseases,” Cancer Research, vol. 58, no. 18, pp. 4122–4126, 1998. View at Google Scholar · View at Scopus
  6. S. Pavanello, L. Dioni, M. Hoxha et al., “Mitochondrial DNA copy number and exposure to polycyclic aromatic hydrocarbons,” Cancer Epidemiology, Biomarkers and Prevention, vol. 22, pp. 1722–1729, 2013. View at Google Scholar
  7. R. Galati, A. Zijno, R. Crebelli et al., “Detection of antibodies to the Benzo(a)pyrene diol epoxide-DNA adducts in sera from individuals exposed to low doses of polycyclic aromatic hydrocarbons,” Journal of Experimental and Clinical Cancer Research, vol. 20, no. 3, pp. 359–364, 2001. View at Google Scholar · View at Scopus
  8. N. Balato, L. Di Costanzo, F. Ayala et al., “Psoriatic disease and tuberculosis nowadays,” Clinical and Developmental Immunology, vol. 2012, Article ID 747204, 10 pages, 2012. View at Publisher · View at Google Scholar
  9. R. Gupta, M. Debbaneh, D. Butler et al., “The Goeckerman regimen for the treatment of moderate to severe psoriasis,” Journal of Visualized Experiments, vol. 77, Article ID e50509, 2013. View at Google Scholar
  10. M. L. Orseth and T. G. Cropley, “What's in a Name?: Goeckerman therapy,” JAMA Dermatology, vol. 149, pp. 1409–1409, 2013. View at Google Scholar
  11. A. G. Hendriks, R. R. Keijsers, E. M. de Jong et al., “Combinations of classical time-honoured topicals in plaque psoriasis: a systematic review,” Journal of the European Academy of Dermatology and Venereology, vol. 27, pp. 399–410, 2013. View at Google Scholar
  12. A. Zampetti, A. Barone, D. Antuzzi et al., “Topical preparations for the treatment of psoriasis: results of a retrospective study over 15 years,” Journal of Dermatological Treatment, vol. 19, no. 3, pp. 134–140, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. L. Moscaliuc, M. M. Heller, E. Lee et al., “Goeckerman therapy: a very effective, yet often forgotten treatment for severe generalized psoriasis,” Journal of Dermatological Treatment, vol. 24, pp. 34–37, 2013. View at Google Scholar
  14. L. Borska, Z. Fiala, C. Andrys et al., “Goeckerman's regimen: genotoxic, pro-apoptotic, anti-inflamatory and anti-angiogenic effect,” in Dermatology Research: Focus on Acne, Melanoma, and Psoriasis, F. Columbus, Ed., vol. 11788, pp. 141–165, Nova Science Publishers, Hauppauge, NY, USA, 2010. View at Google Scholar
  15. W. Peter Arnold, “Tar,” Clinics in Dermatology, vol. 15, no. 5, pp. 739–744, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. K. V. Paghdal and R. A. Schwartz, “Topical tar: back to the future,” Journal of the American Academy of Dermatology, vol. 61, no. 2, pp. 294–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Borska, J. Smejkalova, M. Cerna et al., “Urinary mutagenicity and genotoxic risk in children with psoriasis after therapeutic exposure to polycyclic aromatic hydrocarbons and ultraviolet radiation,” Mutation Research: Genetic Toxicology and Environmental Mutagenesis, vol. 696, no. 2, pp. 144–147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. Cosmetic Ingredient Review Expert Panel, “Final safety assessment of coal tar as used in cosmetics,” International Journal of Toxicology, vol. 27, pp. 1–24, 2008. View at Google Scholar
  19. Food and Drug Administration, HHS (FDA), “seborrheic dermatitis, and psoriasis drug products containing coal tar and menthol for over-the counter human use, amendment to themonograph. Final rule,” Federal Register, vol. 72, pp. 9849–9852, 2007. View at Google Scholar
  20. J. H. J. Roelofzen, K. K. H. Aben, P. G. M. van der Valk, J. L. M. van Houtum, P. C. M. van de Kerkhof, and L. A. L. M. Kiemeney, “Coal tar in dermatology,” Journal of Dermatological Treatment, vol. 18, no. 6, pp. 329–334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. de Rie, A. Y. Goedkoop, and J. D. Bos, “Overview of psoriasis,” Dermatologic Therapy, vol. 17, no. 5, pp. 341–349, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. R. M. Santella, F. P. Perera, T. L. Young et al., “Polycyclic aromatic hydrocarbon-DNA and protein adducts in coal tar treated patients and controls and their relationship to glutathione S-transferase genotype,” Mutation Research: Environmental Mutagenesis and Related Subjects, vol. 334, no. 2, pp. 117–124, 1995. View at Google Scholar · View at Scopus
  23. J. Topinka, A. Milcova, H. Libalova et al., “Biomarkers of exposure to tobacco smoke and environmental pollutants in mothers and their transplacental transfer to the foetus. Part I: bulky DNA adducts,” Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, vol. 669, no. 1-2, pp. 13–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Pulerà, S. Petruzzelli, A. Celi et al., “Presence and persistence of serum anti-benzo[a]pyrene diolepoxide-DNA adduct antibodies in smokers: effects of smoking reduction and cessation,” International Journal of Cancer, vol. 70, pp. 145–149, 1997. View at Google Scholar
  25. C. S. Robbins, D. E. Dawe, S. I. Goncharova et al., “Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness,” The American Journal of Respiratory Cell and Molecular Biology, vol. 30, no. 2, pp. 202–211, 2004. View at Publisher · View at Google Scholar · View at Scopus